1. Validation of the 18F-FDG PET image biomarker model predicting late xerostomia after head and neck cancer radiotherapy
- Author
-
Yan Li, Nanna Maria Sijtsema, Suzanne Petronella Maria de Vette, Roel Johannes Henricus Marinus Steenbakkers, Fan Zhang, Walter Noordzij, Lisa Van den Bosch, Johannes Albertus Langendijk, Lisanne Vania van Dijk, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), and Damage and Repair in Cancer Development and Cancer Treatment (DARE)
- Subjects
Radiomics ,Oncology ,Model validation ,Radiology, Nuclear Medicine and imaging ,Hematology ,FDG-PET ,Head and neck cancer ,Xerostomia - Abstract
Background and purpose: Previously, PET image biomarkers (PET-IBMs) – the 90th percentile standardized uptake value (P90-SUV) and the Mean SUV (Mean-SUV) of the contralateral parotid gland (cPG) – were identified as predictors for late-xerostomia following head and neck cancer (HNC) radiotherapy. The aim of the current study was to assess in an independent validation cohort whether these pre-treatment PET-IBM can improve late-xerostomia prediction compared to the prediction with baseline xerostomia and mean cPG dose alone. Materials and methods: The prediction endpoint was patient-rated moderate-to-severe xerostomia at 12 months after radiotherapy. The PET-IBMs were extracted from pre-treatment 18 F-FDG PET images. The performance of the model (base model) with baseline xerostomia and mean cPG dose alone and models with additionally P90-SUV or Mean-SUV were tested in the current independent validation cohort. Specifically, model discrimination (area under the curve: AUC) and calibration (calibration plot) were evaluated. Results: The current validation cohort consisted of 137 patients of which 40% developed moderate-to-severe xerostomia at 12 months. Both the PET-P90 model (AUC:PET-P90 = 0.71) and the PET-Mean model (AUC: PET-Mean = 0.70) performed well in the current validation cohort. Moreover, their performance were improved compared to the base model (AUC:base model= 0.68). The calibration plots showed a good fit of the prediction to the actual rates for all tested models. Conclusion: PET-IBMs showed an improved prediction of late-xerostomia when added to the base model in this validation cohort. This contributed to the published hypothesis that PET-IBMs include individualized information and can serve as a pre-treatment risk factor for late-xerostomia.
- Published
- 2023